| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 131, 254-260, Copyright © 1992 by Endocrine Society
ARTICLES |
N Ravindranath, L Little-Ihrig, HS Phillips, N Ferrara and AJ Zeleznik
Department of Physiology, University of Pittsburgh School of Medicine, Pennsylvania 15261.
We studied the distribution of messenger RNA (mRNA) that encodes for vascular endothelial growth factor (VEGF) within the primate ovary by in situ hybridization and Northern analysis to determine if the presence of mRNA for this angiogenic factor is associated with structures within the ovary in which angiogenesis is thought to play a role in development and/or function. In situ hybridization to sections of cynomolgus ovaries with a 35S-labeled antisense RNA probe revealed specific tissue localization within the follicle as well as the corpus luteum, but not stromal tissue. Intense expression of mRNA for VEGF during the late follicular phase was confined to the maturing follicle which, we presume, was destined for ovulation. Hybridization within the corpus luteum exhibited a punctate pattern suggesting that there may be specific cells within the corpus luteum that express mRNA for VEGF. The expression of mRNA for VEGF during the early and late luteal phase of the menstrual cycle was studied by Northern analysis. Messenger RNAs were detectable at approximately 3.7 and 5.0 kb positions in corpora lutea collected during the early luteal phase of the menstrual cycle (days 3-5 postovulation). No hybridization signals were observed with RNA prepared from regressing corpora lutea (1-2 days following the onset of menses). The gonadotropic regulation of the expression of mRNA for VEGF in the corpus luteum was studied by treating monkeys with a potent GnRH antagonist during the midluteal phase of the menstrual cycle. Administration of the antagonist for 1 or 2 days did not alter the expression of mRNA for VEGF in comparison to corresponding controls. However, a 3-day treatment regimen brought about a significant reduction in the levels of mRNA for VEGF (P less than 0.01). These studies demonstrate a development-related expression of mRNA for VEGF in the ovary during the menstrual cycle and are consistent with the hypothesis that VEGF may play important roles in follicle selection and corpus luteum function in primates.
This article has been cited by other articles:
![]() |
M. Tesone, R. L. Stouffer, S. M. Borman, J. D. Hennebold, and T. A. Molskness Vascular Endothelial Growth Factor (VEGF) Production by the Monkey Corpus Luteum During the Menstrual Cycle: Isoform-Selective Messenger RNA Expression In Vivo and Hypoxia-Regulated Protein Secretion In Vitro Biol Reprod, November 1, 2005; 73(5): 927 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xu, R.L. Stouffer, R.P. Searles, and J.D. Hennebold Discovery of LH-regulated genes in the primate corpus luteum Mol. Hum. Reprod., March 1, 2005; 11(3): 151 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Gruemmer, L Klein-Hitpass, and J Neulen Regulation of gene expression in endothelial cells: the role of human follicular fluid J. Mol. Endocrinol., February 1, 2005; 34(1): 37 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Sakurai, K Tamura, and H Kogo Vascular endothelial growth factor increases messenger RNAs encoding cyclooxygenase-II and membrane-associated prostaglandin E synthase in rat luteal cells J. Endocrinol., December 1, 2004; 183(3): 527 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
P D Taylor, S G Hillier, and H M Fraser Effects of GnRH antagonist treatment on follicular development and angiogenesis in the primate ovary J. Endocrinol., October 1, 2004; 183(1): 1 - 17. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ferrara Vascular Endothelial Growth Factor: Basic Science and Clinical Progress Endocr. Rev., August 1, 2004; 25(4): 581 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Santoro, B. Isaac, G. Neal-Perry, T. Adel, L. Weingart, A. Nussbaum, S. Thakur, H. Jinnai, N. Khosla, and D. Barad Impaired Folliculogenesis and Ovulation in Older Reproductive Aged Women J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5502 - 5509. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nalbandian, L. Dettin, M. Dym, and N. Ravindranath Expression of Vascular Endothelial Growth Factor Receptors During Male Germ Cell Differentiation in the Mouse Biol Reprod, September 1, 2003; 69(3): 985 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ferrara, G. Frantz, J. LeCouter, L. Dillard-Telm, T. Pham, A. Draksharapu, T. Giordano, and F. Peale Differential Expression of the Angiogenic Factor Genes Vascular Endothelial Growth Factor (VEGF) and Endocrine Gland-Derived VEGF in Normal and Polycystic Human Ovaries Am. J. Pathol., June 1, 2003; 162(6): 1881 - 1893. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.C. Martinez-Chequer, R.L. Stouffer, T.M. Hazzard, P.E. Patton, and T.A. Molskness Insulin-Like Growth Factors-1 and -2, but not Hypoxia, Synergize with Gonadotropin Hormone to Promote Vascular Endothelial Growth Factor-A Secretion by Monkey Granulosa Cells from Preovulatory Follicles Biol Reprod, April 1, 2003; 68(4): 1112 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Hazzard, F. Xu, and R. L. Stouffer Injection of Soluble Vascular Endothelial Growth Factor Receptor 1 into the Preovulatory Follicle Disrupts Ovulation and Subsequent Luteal Function in Rhesus Monkeys Biol Reprod, October 1, 2002; 67(4): 1305 - 1312. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Zimmermann, E. Xiao, P. Bohlen, and M. Ferin Administration of Antivascular Endothelial Growth Factor Receptor 2 Antibody in the Early Follicular Phase Delays Follicular Selection and Development in the Rhesus Monkey Endocrinology, July 1, 2002; 143(7): 2496 - 2502. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wulff, H. Wilson, S. J. Wiegand, J. S. Rudge, and H. M. Fraser Prevention of Thecal Angiogenesis, Antral Follicular Growth, and Ovulation in the Primate by Treatment with Vascular Endothelial Growth Factor Trap R1R2 Endocrinology, July 1, 2002; 143(7): 2797 - 2807. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Vollmar, M. W. Laschke, R. Rohan, J. Koenig, and M. D. Menger In Vivo Imaging of Physiological Angiogenesis from Immature to Preovulatory Ovarian Follicles Am. J. Pathol., November 1, 2001; 159(5): 1661 - 1670. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Quintana, L. Kopcow, G. Marconi, C. Sueldo, G. Speranza, and R.I. Baranao Relationship of ovarian stimulation response with vascular endothelial growth factor and degree of granulosa cell apoptosis Hum. Reprod., September 1, 2001; 16(9): 1814 - 1818. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Zeleznik Follicle Selection in Primates: ""Many Are Called but Few Are Chosen"" Biol Reprod, September 1, 2001; 65(3): 655 - 659. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Redmer, V. Doraiswamy, B. J. Bortnem, K. Fisher, A. Jablonka-Shariff, A. T. Grazul-Bilska, and L. P. Reynolds Evidence for a Role of Capillary Pericytes in Vascular Growth of the Developing Ovine Corpus Luteum Biol Reprod, September 1, 2001; 65(3): 879 - 889. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Shang, I. Konidari, and D. W. Schomberg 2-Methoxyestradiol, an Endogenous Estradiol Metabolite, Differentially Inhibits Granulosa and Endothelial Cell Mitosis: A Potential Follicular Antiangiogenic Regulator Biol Reprod, August 1, 2001; 65(2): 622 - 627. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wulff, H. Wilson, J. S. Rudge, S. J. Wiegand, S. F. Lunn, and H. M. Fraser Luteal Angiogenesis: Prevention and Intervention by Treatment with Vascular Endothelial Growth Factor TrapA40 J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3377 - 3386. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wulff, S. J. Wiegand, P. T. K. Saunders, G. A. Scobie, and H. M. Fraser Angiogenesis During Follicular Development in the Primate and its Inhibition by Treatment with Truncated Flt-1-Fc (Vascular Endothelial Growth Factor TrapA40) Endocrinology, July 1, 2001; 142(7): 3244 - 3254. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.L. Benifla, A.F. Bringuier, C. Sifer, R. Porcher, P. Madelenat, and G. Feldmann Vascular endothelial growth factor, platelet endothelial cell adhesion molecule-1 and vascular cell adhesion molecule-1 in the follicular fluid of patients undergoing IVF Hum. Reprod., July 1, 2001; 16(7): 1376 - 1381. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ferrara Role of vascular endothelial growth factor in regulation of physiological angiogenesis Am J Physiol Cell Physiol, June 1, 2001; 280(6): C1358 - C1366. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Zimmermann, E. Xiao, N. Husami, M. V. Sauer, R. Lobo, J. Kitajewski, and M. Ferin Short-Term Administration of Antivascular Endothelial Growth Factor Antibody in the Late Follicular Phase Delays Follicular Development in the Rhesus Monkey J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 768 - 772. [Abstract] [Full Text] |
||||
![]() |
S. Kashida, N. Sugino, S. Takiguchi, A. Karube, H. Takayama, Y. Yamagata, Y. Nakamura, and H. Kato Regulation and Role of Vascular Endothelial Growth Factor in the Corpus Luteum During Mid-Pregnancy in Rats Biol Reprod, January 1, 2001; 64(1): 317 - 323. [Abstract] [Full Text] |
||||
![]() |
C. Wulff, H. Wilson, P. Largue, W. C. Duncan, D. G. Armstrong, and H. M. Fraser Angiogenesis in the Human Corpus Luteum: Localization and Changes in Angiopoietins, Tie-2, and Vascular Endothelial Growth Factor Messenger Ribonucleic Acid J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4302 - 4309. [Abstract] [Full Text] |
||||
![]() |
T.M. Hazzard, L.K. Christenson, and R.L. Stouffer Changes in expression of vascular endothelial growth factor and angiopoietin-1 and -2 in the macaque corpus luteum during the menstrual cycle Mol. Hum. Reprod., November 1, 2000; 6(11): 993 - 998. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sugino, S. Kashida, S. Takiguchi, A. Karube, and H. Kato Expression of Vascular Endothelial Growth Factor and Its Receptors in the Human Corpus Luteum during the Menstrual Cycle and in Early Pregnancy J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3919 - 3924. [Abstract] [Full Text] |
||||
![]() |
B. Berisha, D. Schams, M. Kosmann, W. Amselgruber, and R. Einspanier Expression and Tissue Concentration of Vascular Endothelial Growth Factor, Its Receptors, and Localization in the Bovine Corpus Luteum During Estrous Cycle and Pregnancy Biol Reprod, October 1, 2000; 63(4): 1106 - 1114. [Abstract] [Full Text] |
||||
![]() |
C. Tempel, A. Gilead, and M. Neeman Hyaluronic Acid as an Anti-Angiogenic Shield in the Preovulatory Rat Follicle Biol Reprod, July 1, 2000; 63(1): 134 - 140. [Abstract] [Full Text] |
||||
![]() |
H. M. Fraser, S. E. Dickson, S. F. Lunn, C. Wulff, K. D. Morris, V. A. Carroll, and R. Bicknell Suppression of Luteal Angiogenesis in the Primate after Neutralization of Vascular Endothelial Growth Factor Endocrinology, March 1, 2000; 141(3): 995 - 1000. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.M. Hazzard, T.A. Molskness, C.L. Chaffin, and R.L. Stouffer Vascular endothelial growth factor (VEGF) and angiopoietin regulation by gonadotrophin and steroids in macaque granulosa cells during the peri-ovulatory interval Mol. Hum. Reprod., December 1, 1999; 5(12): 1115 - 1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Krussel, E. M. Casan, F. Raga, J. Hirchenhain, Y. Wen, H.-Y. Huang, P. Bielfeld, and M. L. Polan Expression of mRNA for vascular endothelial growth factor transmembraneous receptors Flt1 and KDR, and the soluble recetor sflt in cycling human endometrium Mol. Hum. Reprod., May 1, 1999; 5(5): 452 - 458. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Doldi, A. Destefani, A. Gessi, D. Grossi, and A. Ferrari Human albumin enhances expression of vascular endothelial growth factor in cultured human luteinizing granulosa cells: importance in ovarian hyperstimulation syndrome Hum. Reprod., May 1, 1999; 14(5): 1157 - 1159. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Ryan, D. B. Eppler, K. E. Hagler, R. H. Bruner, P. J. Thomford, R. L. Hall, G. M. Shopp, and C. A. O'Neill Preclinical Safety Evaluation of rhuMAbVEGF, an Antiangiogenic Humanized Monoclonal Antibody Toxicol Pathol, January 1, 1999; 27(1): 78 - 86. [Abstract] [PDF] |
||||
![]() |
A. J. Zeleznik In vivo responses of the primate corpus luteum to luteinizing hormone and chorionic gonadotropin PNAS, September 1, 1998; 95(18): 11002 - 11007. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Laitinen, A. RistimAki, M. Honkasalo, K. Narko, K. Paavonen, and O. Ritvos Differential Hormonal Regulation of Vascular Endothelial Growth Factors VEGF, VEGF-B, and VEGF-C Messenger Ribonucleic Acid Levels in Cultured Human Granulosa-Luteal Cells Endocrinology, November 1, 1997; 138(11): 4748 - 4756. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Christenson and R. L. Stouffer Follicle-Stimulating Hormone and Luteinizing Hormone/Chorionic Gonadotropin Stimulation of Vascular Endothelial Growth Factor Production by Macaque Granulosa Cells from Pre- and Periovulatory Follicles J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2135 - 2142. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ferrara and T. Davis-Smyth The Biology of Vascular Endothelial Growth Factor Endocr. Rev., February 1, 1997; 18(1): 4 - 25. [Abstract] [Full Text] |
||||
![]() |
M. Clauss, H. Weich, G. Breier, U. Knies, W. Rockl, J. Waltenberger, and W. Risau The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities. IMPLICATIONS FOR A FUNCTIONAL ROLE OF PLACENTA GROWTH FACTOR IN MONOCYTE ACTIVATION AND CHEMOTAXIS J. Biol. Chem., July 26, 1996; 271(30): 17629 - 17634. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |